Safe care, measurable quality

At My Nova, we see quality not only as compliance with standards, but as the responsibility to provide every patient with safe, appropriate, scientific and continuously improved healthcare.

Patient safety and clinical effectiveness form the foundation of our approach to care. We carry out our treatment processes in accordance with current scientific knowledge, professional guidelines and evidence-based practices, focusing on preventing risks before they arise wherever possible.

We believe that quality can only be improved when it is measured. For this reason, we regularly monitor our clinical outcomes, patient safety incidents, risks, patient experience, feedback and defined performance indicators, and use the results to improve our services.

Scientific and Safe Treatment

We support our clinical decisions with current scientific knowledge, evidence-based practices and professional guidelines.

Preventing Risks

We assess patient safety risks, near misses and adverse events, and establish improvement actions when necessary.

Measuring Outcomes

Treatment outcomes, complications, retreatment rates and defined clinical indicators are regularly evaluated. The systematic monitoring of clinical outcomes is also defined as one of the main objectives in the quality plan.

Listening to Patient Experience

We see satisfaction, suggestions and complaints not only as feedback, but as an important source of data that improves our services. Regular analysis of patient experience and feedback is also included as a separate area for improvement in the quality plan.

We Monitor Our Quality Through Data

We believe that what the figures mean for our patients matters more than the figures alone. For this reason, we regularly follow data that show not only our performance, but also treatment outcomes, patient experience and the safety of care.

96.5%

Patient Satisfaction

This shows our patients’ overall experience of the services they receive. We monitor it to understand how well communication, information, coordination and the service experience meet expectations.

January–June 2026 average

4.87 / 5

Patient Assessment After Implant Treatment

This shows how our patients assess the outcome of implant treatment in areas such as pain and discomfort, chewing and function, fulfilment of expectations and aesthetic results. We monitor it to evaluate treatment success not only clinically, but also in terms of its impact on the patient’s daily life.

Additional information: Chewing and function assessment: 4.90 / 5.Implant patients followed up during January–September 2026 · 71 patients

0%–2.6%

Retreatment Rate After Fillings

This shows whether a tooth that has received a filling requires retreatment within the first 6 months. We monitor it to evaluate the short-term clinical success of filling treatments and the continuity of treatment.

Current 2026 measurements · Target ≤ 5%

0%

Retreatment Rate After Root Canal Treatment

This shows whether a tooth that has received root canal treatment requires retreatment within the first 6 months. We monitor it to follow the short-term clinical outcome of treatment and the need for further intervention.

Current 2026 measurements · Target ≤ 8%

100%

Sterilisation Control Compliance

This shows the compliance of biological, chemical and other critical control indicators used to verify the effectiveness of the sterilisation process. We monitor it to ensure not only that sterilisation is performed, but also that its effectiveness is regularly verified, and to reduce the risk of infection.

Bowie-Dick, protein residue, chemical and biological indicators · January–June 2026

0.83%

Repeat Radiographic Imaging Rate

This shows the proportion of examinations requiring a repeat diagnostic image among all examinations. We monitor it to maintain image quality while minimising patients’ unnecessary exposure to radiation from repeat imaging.

January–June 2026 average · Target ≤ 5%

Continuous Improvement

We use quality indicators not only to show good results, but also to identify areas needing improvement at an early stage. Deviations from targets, patient feedback, clinical outcomes and safety data are evaluated by the relevant teams; improvement actions are planned when necessary and their results are followed up. The systematic evaluation of clinical outcomes, patient safety incidents, infection control and patient experience in this way is among the main areas for improvement in My Nova’s quality plan.